We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
FUSN | Fusion Pharmaceuticals Inc | 20.74 | 10.10 | 94.92% | 211,262 |
OTRK | Ontrak Inc | 0.353 | 0.163 | 85.79% | 4,329,510 |
ZCAR | Zoomcar Holdings Inc | 1.86 | 0.68 | 57.63% | 7,305,316 |
SUGP | SU Group Holdings Ltd | 3.78 | 0.74 | 24.34% | 1 |
NCMI | National CineMedia Inc | 5.24 | 1.02 | 24.17% | 28,775 |
LFLY | Leafly Holdings Inc | 3.00 | 0.58 | 23.97% | 10 |
CJET | Chijet Motor Company Inc | 0.7102 | 0.1299 | 22.38% | 986,175 |
LGHLW | Lion Group Holding Ltd | 0.0067 | 0.0011 | 19.64% | 13 |
VERB | Verb Technology Company Inc | 0.4218 | 0.0618 | 17.17% | 3,269,056 |
EZFL | EzFill Holdings Inc | 2.05 | 0.28 | 15.82% | 2 |
GRDI | GRIID Infrastructure Inc | 1.08 | 0.1443 | 15.42% | 147 |
Transaction includes actinium-based clinical-stage radioconjugate targeting PSMA for prostate cancer, pipeline of radioconjugates and state-of-the-art R&D and manufacturing facilities Fusion shareholders to receive $21.00 per share in cash at closing plus a non-transferrable contingent value right (CVR) of $3.00 per share, representing a total transaction value of approximately $2.4 billion including the CVR HAMILTON, ON and BOSTON, March 19, 2024 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, today announced the Company has entered into a definitive agreement to be acquired by AstraZeneca. The acquisition marks a major step ...
National CineMedia, Inc. (NASDAQ: NCMI) (“the Company” or “NCM”), the managing member of National CineMedia, LLC (“NCM LLC”), the operator of the largest cinema advertising platform in the U.S., today announced its results for the fourth quarter and full year 2023, ended December 28, 2023.
Sarcos Technology and Robotics Corporation (“Sarcos”) (NASDAQ: STRC and STRCW) is pleased to announce that effective today, the company has changed its name to Palladyne AI Corp. (Palladyne AI). Effective April 8, 2024, the Company’s ticker symbol will change from NASDAQ: STRC to NASDAQ: PDYN. The new name reflects the company's narrowed focus on commercializing the artificial intelligence and machine learning software that it has been developing since 2020.
NEW YORK, March 18, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Martha S. Rook as its new Chief Operating Officer (COO).
Rank | Board Name | Posts (24h) |
---|---|---|
ORIONS Money Stocks | 176 | |
BBs Stock Haven | 148 | |
MOMOS BREAKOUT BOARD | 106 | |
4 | Dutchman Stocks | 32 |
5 | Savvy Trades and Investments | 25 |
6 | Da Burbs 2 0 | 22 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 63,032.00 | -4,541.71 | -6.72% | 1.26T | 8,608,184,836 |
ETH | Ethereum | 3,218.83 | -298.05 | -8.47% | 395.02B | 4,602,640,426 |
USDT | Tether USD | 0.99973 | -0.00012 | -0.01% | 97.8B | 384,744,334 |
BNB | Binance Coin | 506.77 | -48.49 | -8.73% | 81.57B | 1,445,903,980 |
SOL | Solana | 173.63 | -21.71 | -11.11% | 79.04B | 4,253,342,411 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |